NanoViricides, Inc. (NNVC) stock

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026Score 5/30

$1.23−0.12 (-8.89%)

Close on Nov 13, 2026Market cap $31.40MP/E –Yield –

NanoViricides ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

NanoViricides has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in NanoViricides's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 24, 2019
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NNVC.

Advertisement
300 × 250

See a number that looks wrong?